Cover Image
QR Code

Reevaluating Cell and Gene Therapy Development: The industry considers applying automation and digitalization lessons learned during the COVID-19 pandemic to enhance workflows.

Published in:BioPharm International Vol. 34; no. 9; pp. 18 - 20
Main Author: PIKE, NIRUPAMA (RUPA)
Format: Journal Article
Published: MJH Life Sciences Sep2021
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152341121&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 152341121
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Sep2021
      vid: 34
      iid: 9
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        152341121
        152341121
      ppf: 18
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Reevaluating Cell and Gene Therapy Development: The industry considers applying automation and digitalization lessons learned during the COVID-19 pandemic to enhance workflows.
      aug:
        au: PIKE, NIRUPAMA (RUPA)
        affil: Director of Enterprise Science and Innovation Partnerships at Thermo Fisher Scientific
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N